Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Insider Selling

Every insider selling trade by a US-listed company that our alert engine sent, newest first.

5:53 PM ET Form 4
Insider Selling Mineralys Therapeutics, Inc. MLYS

Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock

Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).

Value
$1.91M
Shares
75,000
Price
$25.46
Role
CEO
Holding change
-12.4%
Trade date
Sep 30, 2026
5:51 PM ET Form 4
Insider Selling Rivian Automotive, Inc. RIVN

Rivian Automotive Chief Administrative Officer Michael John Callahan Sells $225K of Stock

Michael John Callahan, Chief Administrative Officer, sold 15,000 shares of Rivian Automotive, Inc. at $15.00 a share, worth $225K in total on Oct 1, 2026. Shares held after the trade: 1,001,776 (-1.5%).

Value
$225K
Shares
15,000
Price
$15.00
Role
Chief Administrative Officer
Holding change
-1.5%
Trade date
Oct 1, 2026
5:51 PM ET Form 4
Insider Selling Oric Pharmaceuticals, Inc. ORIC

Oric Pharmaceuticals Director Richard A. Heyman Sells $86.5K of Stock

Richard A. Heyman, Director, sold 6,700 shares of Oric Pharmaceuticals, Inc. at $12.91 a share, worth $86.5K in total on Oct 1, 2026. Shares held after the trade: 203,472 (-1.5%).

Value
$86.5K
Shares
6,700
Average price
$12.91
Role
Director
Holding change
-1.5%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Rubrik, Inc. RBRK

Rubrik Director John Wendell Thompson Sells $1.56M of Stock

John Wendell Thompson, Director, sold 13,500 shares of Rubrik, Inc. at $114.68 to $116.47 a share (average $115.69) in 6 transactions, worth $1.56M in total on Oct 1, 2026. Shares held after the trade: 8,362 (-22.3%).

Value
$1.56M
Shares
13,500
Average price
$115.69
Role
Director
Holding change
-22.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus Chairman and CEO Scott Bender Sells $6.2M of Stock

Scott Bender, Chairman and CEO, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 120,527 (-45.3%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
Chairman and CEO
Holding change
-45.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus President Joel Bender Sells $6.2M of Stock

Joel Bender, President, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 41,519 (-70.7%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
President
Holding change
-70.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling First Solar, Inc. FSLR

First Solar CTO Markus Gloeckler Sells $139K of Stock

Markus Gloeckler, CTO, sold 800 shares of First Solar, Inc. at $174.00 a share, worth $139K in total on Oct 1, 2026. Shares held after the trade: 5,042 (-13.7%).

Value
$139K
Shares
800
Price
$174.00
Role
CTO
Holding change
-13.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling Anaptysbio, Inc ANAB

Anaptysbio Director Hollings Renton Sells $249K of Stock

Hollings Renton, Director, sold 5,000 shares of Anaptysbio, Inc at $49.87 a share, worth $249K in total on Oct 1, 2026. Shares held after the trade: 10,995 (-31.3%).

Value
$249K
Shares
5,000
Price
$49.87
Role
Director
Holding change
-31.3%
Trade date
Oct 1, 2026
5:38 PM ET Form 4
Insider Selling Roivant Sciences Ltd. ROIV

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.62 a share, worth $7.32M in total on Sep 30, 2026. Shares held after the trade: 1,599,154 (-11.1%).

Value
$7.32M
Shares
200,000
Price
$36.62
Role
President & Immunovant CEO
Holding change
-11.1%
Trade date
Sep 30, 2026
5:37 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock

Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).

Value
$16.5K
Shares
627
Price
$26.33
Role
General Counsel & Corp Sec
Holding change
-3.0%
Trade date
Oct 2, 2026
5:36 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock

Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).

Value
$27.5K
Shares
1,051
Price
$26.16
Role
CMO
Holding change
-5.2%
Trade date
Oct 1, 2026
5:34 PM ET Form 4
Insider Selling Walmart Inc. WMT

Walmart EVP Daniel J. Bartlett Sells $417K of Stock

Daniel J. Bartlett, EVP, sold 3,990 shares of Walmart Inc. at $104.41 a share, worth $417K in total on Oct 1, 2026. Shares held after the trade: 618,359 (-0.6%).

Value
$417K
Shares
3,990
Price
$104.41
Role
EVP
Holding change
-0.6%
Trade date
Oct 1, 2026
5:31 PM ET Form 4
Insider Selling Cardlytics, Inc. CDLX

Cardlytics CEO Amit Gupta Sells $46.7K of Stock

Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).

Value
$46.7K
Shares
17,733
Average price
$2.64
Role
CEO
Holding change
-5.0%
Trade date
Oct 1, 2026 to Oct 2, 2026
5:21 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock

Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).

Value
$782K
Shares
12,000
Price
$65.16
Role
Director
Holding change
-34.8%
Trade date
Sep 30, 2026
5:20 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).

Value
$9.93M
Shares
140,157
Average price
$70.82
Role
CFO
Holding change
-1.3%
Trade date
Oct 1, 2026
5:20 PM ET Form 4
Insider Selling Ceribell, Inc. CBLL

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock

Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).

Value
$90.2K
Shares
20,000
Price
$4.51
Role
CFO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals COO & Cbo Joshua Hexter Sells $135K of Stock

Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).

Value
$135K
Shares
30,000
Price
$4.51
Role
COO & Cbo
Holding change
-2.2%
Trade date
Oct 1, 2026
5:16 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem President and CEO Dan Paterson Sells $353K of Stock

Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).

Value
$353K
Shares
44,121
Price
$8.00
Role
President and CEO
Holding change
-6.3%
Trade date
Oct 1, 2026
5:15 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem CFO Daniel Calkins Sells $20.5K of Stock

Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).

Value
$20.5K
Shares
2,566
Price
$8.00
Role
CFO
Holding change
-2.0%
Trade date
Oct 1, 2026
5:14 PM ET Form 4
Insider Selling Coursera, Inc. COUR

Coursera President & CEO Gregory M. Hart Sells $52.6K of Stock

Gregory M. Hart, President & CEO, sold 10,308 shares of Coursera, Inc. at $5.11 a share, worth $52.6K in total on Oct 1, 2026. Shares held after the trade: 1,539,003 (-0.7%).

Value
$52.6K
Shares
10,308
Price
$5.11
Role
President & CEO
Holding change
-0.7%
Trade date
Oct 1, 2026
5:13 PM ET Form 4
Insider Selling Generac Holdings Inc. GNRC

Generac Holdings CEO Aaron Jagdfeld Sells $1.03M of Stock

Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $206.00 a share, worth $1.03M in total on Oct 1, 2026. Shares held after the trade: 544,528 (-0.9%).

Value
$1.03M
Shares
5,000
Price
$206.00
Role
CEO
Holding change
-0.9%
Trade date
Oct 1, 2026
5:10 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Insider Jeffrey Jacob Raider Sells $416K of Stock

Jeffrey Jacob Raider sold 15,000 shares of Warby Parker Inc. at $27.70 a share, worth $416K in total on Oct 1, 2026. Shares held after the trade: 420,201 (-3.4%).

Value
$416K
Shares
15,000
Price
$27.70
Holding change
-3.4%
Trade date
Oct 1, 2026
5:09 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Co-CEO Neil Harris Blumenthal Sells $2.77M of Stock

Neil Harris Blumenthal, Co-CEO, sold 100,000 shares of Warby Parker Inc. at $27.69 a share, worth $2.77M in total on Oct 1, 2026. Shares held after the trade: 36,020 (-73.5%).

Value
$2.77M
Shares
100,000
Price
$27.69
Role
Co-CEO
Holding change
-73.5%
Trade date
Oct 1, 2026
5:01 PM ET Form 4
Insider Selling Tectonic Therapeutic, Inc. TECX

Tectonic Therapeutic CSO Peter McNamara Sells $12.3K of Stock

Peter McNamara, CSO, sold 536 shares of Tectonic Therapeutic, Inc. at $23.04 a share, worth $12.3K in total on Sep 30, 2026. Shares held after the trade: 54,305 (-1.0%).

Value
$12.3K
Shares
536
Price
$23.04
Role
CSO
Holding change
-1.0%
Trade date
Sep 30, 2026
5:00 PM ET Form 4
Insider Selling Bloom Energy Corp BE

Bloom Energy Chief Commercial Officer Aman Joshi Sells $2.34M of Stock

Aman Joshi, Chief Commercial Officer, sold 8,437 shares of Bloom Energy Corp at $277.17 a share, worth $2.34M in total on Oct 1, 2026. Shares held after the trade: 147,092 (-5.4%).

Value
$2.34M
Shares
8,437
Price
$277.17
Role
Chief Commercial Officer
Holding change
-5.4%
Trade date
Oct 1, 2026
4:58 PM ET Form 4
Insider Selling Credo Technology Group Holding Ltd CRDO

Credo Technology Group Holding COO Yat Tung Lam Sells $10.3M of Stock

Yat Tung Lam, COO, sold 50,000 shares of Credo Technology Group Holding Ltd at $205.22 a share, worth $10.3M in total on Oct 1, 2026. Shares held after the trade: 2,254,169 (-2.2%).

Value
$10.3M
Shares
50,000
Price
$205.22
Role
COO
Holding change
-2.2%
Trade date
Oct 1, 2026
4:56 PM ET Form 4
Insider Selling Maximus, Inc. MMS

Maximus Chief of Human Resources Michelle F. Link Sells $174K of Stock

Michelle F. Link, Chief of Human Resources, sold 3,208 shares of Maximus, Inc. at $54.23 a share, worth $174K in total on Oct 1, 2026. Shares held after the trade: 13,881 (-18.8%).

Value
$174K
Shares
3,208
Price
$54.23
Role
Chief of Human Resources
Holding change
-18.8%
Trade date
Oct 1, 2026
4:55 PM ET Form 4
Insider Selling Verisign Inc VRSN

Verisign EVP, Gen Counsel & Secretary Thomas C. Indelicarto Sells $142K of Stock

Thomas C. Indelicarto, EVP, Gen Counsel & Secretary, sold 500 shares of Verisign Inc at $284.38 a share, worth $142K in total on Oct 1, 2026. Shares held after the trade: 32,395 (-1.5%).

Value
$142K
Shares
500
Price
$284.38
Role
EVP, Gen Counsel & Secretary
Holding change
-1.5%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.